Company Filing History:

5 out of 4,455

Pfizer Corporation

Merck Sharp + Dohme Corp.

patents

4. 1 out of 832,680

Other

patents

Years Active: 2001-2013

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8552193 - Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide (2013-10-08),

2. 8129413 - Crystalline forms of MC4R agonist and process for synthesis (2012-03-06),

3. 7312334 - Method of preparing inhibitors phosphodiesterase-4 (2007-12-25),

4. 6998488 - Process and intermediates for the preparation of 4-aryl piperidines (2006-02-14),

5. 6909002 - Method of preparing inhibitors of phosphodiesterase-4 (2005-06-21),

6. 6869943 - Sorbitol dehydrogenase inhibitors (2005-03-22),

7. 6727392 - Process for the preparation of non-steroidal glucocorticoid receptor modulators (2004-04-27),

8. 6660740 - Sorbitol dehydrogenase inhibitors (2003-12-09),

9. 6596867 - Tartrate salt of a substituted dipeptide as growth hormone secretagogue (2003-07-22),

10. 6570020 - Process for the preparation of non-steroidal glucocorticoid receptor modulators (2003-05-27),

11. 6248717 - Tartrate salt of a substituted dipeptide as growth hormone secretagogue (2001-06-19),

Title: Jerry Anthony Murry: Innovator and Patent Holder in Pharmaceutical Science

Introduction: Jerry Anthony Murry is a prominent inventor based in Mystic, CT, USA. With an impressive portfolio of 11 patents, Murry has made significant contributions to the field of pharmaceutical innovations, specifically in the area of phosphodiesterase inhibitors and MC4R agonists.

Latest Patents: Among his latest patents is a breakthrough in alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide. This invention focuses on developing alternative forms to enhance its application and efficacy. Additionally, Murry has patented a novel process for synthesizing N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, along with its crystalline salts, hydrates, solvates, and polymorphic forms.

Career Highlights: Murry has garnered extensive experience working for renowned pharmaceutical companies such as Pfizer and Merck & Company, Inc. During his tenure, he has been instrumental in research and development projects, paving the way for innovative drug formulations and therapies.

Collaborations: Throughout his career, Jerry has collaborated with notable colleagues, including Philip Albert Carpino and Paul Andrew Dasilva-Jardine. These partnerships have contributed to the success of various projects and advanced the pharmaceutical sciences.

Conclusion: With his 11 patents and a dedicated career in the pharmaceutical industry, Jerry Anthony Murry continues to inspire aspiring inventors. His innovative contributions have opened new avenues for therapeutic development, securing his place as a key figure in the realm of drug discovery and innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.